IWC Among Its Peers
End-of-day Nov 20, 2026 · 1 ETFs by Max
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −3.2% | −8.8% | −11.1% | −19.5% | +0.8% | +8.7% | +63.0% | +7.7% | +127.5% | +240.2% |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$10 of every $1,000 in IWC is Caredx
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | CDNACaredx | Healthcare | 1.00% | $99.57 | 156K | $11.2M |
| 2 | VRDNViridian Therapeutics ORS | Healthcare | 0.85% | $85.24 | 305K | $9.6M |
| 3 | SLSSellas Life Sciences Group | Healthcare | 0.81% | $80.81 | 612K | $9.1M |
| 4 | XERSXeris Biopharma | Healthcare | 0.77% | $76.93 | 521K | $8.7M |
| 5 | PENGPenguin Solutions | Technology | 0.58% | $57.79 | 153K | $6.5M |
| 6 | PRCHPorch Group | Financial Services | 0.54% | $54.28 | 306K | $6.1M |
| 7 | OUSTOuster | Technology | 0.50% | $50.38 | 201K | $5.7M |
| 8 | TILEInterface | Consumer Cyclical | 0.48% | $48.15 | 178K | $5.4M |
| 9 | MBXMBX Biosciences | Healthcare | 0.45% | $44.75 | 94K | $5.0M |
| 10 | ETONETON Pharmaceuticals | Healthcare | 0.44% | $44.24 | 81K | $5.0M |
| 11 | DCOMDime Commercial Bancshares | Financial Services | 0.44% | $44.05 | 125K | $5.0M |
| 12 | PURRHyperliquid Strategies | Financial Services | 0.44% | $43.60 | 584K | $4.9M |
| 13 | QCRHQCR | Financial Services | 0.43% | $43.33 | 50K | $4.9M |
| 14 | LINDLindblad Expeditions | Consumer Cyclical | 0.42% | $42.21 | 152K | $4.8M |
| 15 | OBKOrigin Bancorp | Financial Services | 0.42% | $42.20 | 92K | $4.8M |
IWC has no close peers in our data yet: […]
No peers with a full year of prices to rank against yet.
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | CDNA | Caredx | 1.00% |
| 2 | VRDN | Viridian Therapeutics ORS | 0.85% |
| 3 | SLS | Sellas Life Sciences Group | 0.81% |
| 4 | XERS | Xeris Biopharma | 0.77% |
| 5 | PENG | Penguin Solutions | 0.58% |
| 6 | PRCH | Porch Group | 0.54% |
| 7 | OUST | Ouster | 0.50% |
| 8 | TILE | Interface | 0.48% |
| 9 | MBX | MBX Biosciences | 0.45% |
| 10 | ETON | ETON Pharmaceuticals | 0.44% |
| Fund | Sharpe | Sortino | Volatility | Max DD | Beta | Fee / $10k |
|---|---|---|---|---|---|---|
| IWC | 0.23 | 0.33 | 24.0% | −21.2% | 1.33 | $60 |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 15, 2026 | Sep 18, 2026 | $0.45 |
| Jun 15, 2026 | Jun 18, 2026 | $0.51 |
| Mar 17, 2026 | Mar 20, 2026 | $0.25 |
| Dec 16, 2025 | Dec 19, 2025 | $0.73 |
| Sep 16, 2025 | Sep 19, 2025 | $0.40 |
| Jun 16, 2025 | Jun 20, 2025 | $0.32 |
| Mar 18, 2025 | Mar 21, 2025 | $0.28 |
| Dec 17, 2024 | Dec 20, 2024 | $0.38 |
| Sep 25, 2024 | Sep 30, 2024 | $0.42 |
| Jun 11, 2024 | Jun 17, 2024 | $0.33 |
| Mar 21, 2024 | Mar 27, 2024 | $0.25 |
| Dec 20, 2023 | Dec 27, 2023 | $0.39 |